Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

ANTXANTX
12 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in AN2 THERAPEUTICS INC

No. RA Capital Management exited its ANTX (AN2 Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 1,999,997 shares worth $2.1M. RA Capital Management first reported ANTX in Q1 2022 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$55.3M

Total Shares Change

-3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$1.41
0
2024-Q3
Decreased
2M
-64.0%
$2.1M0.0%$1.06
0
2024-Q2
Unchanged
5.6M
0.0%
$11.9M0.2%$2.15
0
2024-Q1
Unchanged
5.6M
0.0%
$18M0.2%$3.25
0
2023-Q4
Unchanged
5.6M
0.0%
$113.7M1.8%$20.49
0
2023-Q3
Increased
5.6M
+47.1%
$89.3M1.8%$16.08
64
2023-Q2
Unchanged
3.8M
0.0%
$32.1M0.6%$8.40
0
2023-Q1
Unchanged
3.8M
0.0%
$37.2M0.8%$9.63
0
2022-Q4
Unchanged
3.8M
0.0%
$36M0.7%$9.53
0
2022-Q3
Increased
3.8M
+0.7%
$65.6M1.4%$15.32
47
2022-Q2
Increased
3.7M
+2.2%
$29.1M0.8%$7.91
41
2022-Q1
New
3.7M
-
$55.3M1.2%$15.00
67

Other major holders of ANTX: CITADEL ADVISORS LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used